Merk reported $23.17B in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 14.33B 1.71B
AstraZeneca AZN:LN USD 24.85B 3.04B
Astrazeneca AZN:US USD 24.85B 3.04B
Biogen BIIB:US USD 3.93B 1.09B
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Catalent CTLT:US USD 943M 129M
Coherus Biosciences CHRS:US USD 171.32M 30.56M
Eli Lilly And LLY:US USD 15.65B 32.2M
Endo International Ordinary Shares ENDP:US USD 543.05M 638.62M
Gilead Sciences GILD:US USD 10.42B 1.2B
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Glaxosmithkline GSK:US GBP 20.95B 16.88B
Horizon Pharma HZNP:US USD 860.61M 69.55M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
JAZZ PHA JAZZ:US USD 812.95M 107.51M
Medtronic MDT:US USD 14.47B 416M
Novartis NVS:US USD 28.16B 514M
Novartis NOVN:VX USD 28.16B 514M
Pacira Pharmaceuticals PCRX:US USD 131.53M 1.65M
Perrigo Ordinary Shares PRGO:US USD 1.02B 400K
Phibro Animal Health PAHC:US USD 172.5M 18.33M
Prestige Brands PBH:US USD 152.31M 3.04M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Revance Therapeutics RVNC:US USD 74.73M 2.49M
Roche Holding ROG:VX 27.41B 11.01B
Teva Pharmaceutical Industries TEVA:US USD 11.53B 538M
United Therapeutics UTHR:US USD 315.9M 15.6M
Zoetis ZTS:US USD 2.88B 171M